Topic

FoundationOne Liquid

  • Liquid Biopsy: From an Improbable Idea, New Potential Emerges

    By Prasanth Reddy, MD, MPh, FACP, VP, Medical Affairs, Foundation Medicine and Lucas Dennis, Senior Director, Franchise Development, Foundation Medicine It’s always been an ambitious concept: By analyzing a patient’s blood, doctors might better understand their individual cancer, and thus better pinpoint what …

    Continue Reading

  • A Year of Change and an Exciting Chapter Ahead

    This article was originally published on LinkedIn. December is always a busy time. Suddenly everyone seems to be filled with a sense of urgency and purpose as the holidays approach and the year draws to a close. There’s almost a static charge to the air; a feeling of anticipation around what the new year may bring …

    Continue Reading

  • ESMO 2019: Comprehensive Genomic Profiling Leverages Data Insights to Improve Patient Care

    As scientists worldwide continue to pioneer breakthroughs and change the way we understand and treat advanced cancer, it’s important to stay connected so we can learn from one another. The annual European Society for Medical Oncology (ESMO) Congress is one such opportunity for the cancer community to share the latest …

    Continue Reading

  • Expanding options for more patients: Introducing FoundationOne®Liquid

    With a single tissue biopsy and comprehensive genomic profiling (CGP), people diagnosed with cancer have access to more information about their disease than ever before. These insights are rapidly advancing precision medicine and giving patients the chance to find the treatment most likely to benefit their specific …

    Continue Reading